Cannabidiol (CBD), an extract of marijuana, has beneficial effects in patients with schizophrenia, finds a new multicenter double-blind randomized controlled trial.
Cannabidiol (CBD), an extract of marijuana, has beneficial effects in patients with schizophrenia, finds a new multicenter double-blind randomized controlled trial.
Leave your comment
You must be logged in to post a comment.
